MedPath

Development of Low Back Pain improvement assessment questionnaire and mobile application(Thandaga Track) through the sypmtoms mentioned in Siddha system of medicine.

Not yet recruiting
Conditions
Spondylosis, unspecified,
Registration Number
CTRI/2025/04/085786
Lead Sponsor
Central Council for Research in Siddha.
Brief Summary

**AIM**

To develop and validate a Siddhaprognostic tool and to develop mobile application named (*Thandaga Track*)for assessing prognosis in LBP patients through the Siddha symptomatology.

**OBJECTIVES**

**PRIMARYOBJECTIVE**

To develop andvalidate a *Siddha* prognostic tool and develop a mobile application forSiddha clinicians to assess the prognosis of low back pain (LBP) based onsymptomatology from *Siddha* literature.

**SECONDARYOBJECTIVE**

To document theprognostic scores of Low Back Pain in patients undertaking siddha medication.

**STUDY DESIGN**

Device development

Pilot study – Cross sectional study

**METHODOLOGY**

A multi-phase method will be used in the development of the Siddha mobileapplication for determining the prognosis of low back pain. A comprehensiveliterature review of classical Siddha texts will be conducted using key termssuch as “*iduppu vali, iduppu vatham muthuku vali, mullanthandu vali,pittathil vali, nadappathil siramam, kaal vali and muthuku purathil erichal*”.This approach aims to identify symptoms and clinical presentations associatedwith low back pain and related conditions as described in traditional Siddhamedicine. A structured assessment scale will be developed based on theimportant prognostic markers that are found once this data has been reviewed.Working along with software engineers, the indicators will be converted into aneasily navigable digital version. Features like prognosis visualization,automatic scoring, and symptom input will all be included in the application.In order to improve the application’s accuracy, usability, and clinicalrelevance, iterative testing will be conducted with input from Siddha doctorsand patients. Finally, a pilot study will validate its effectiveness in areal-world clinical setting.

**OUTCOME**

**PRIMARYOUTCOME**

It will provide asystematic and standardized prognostic tool for Siddha clinicians, in the formof a scoring, and to develop a mobile application (*Thandaga Track*) toassess the prognosis of low back pain through *Siddha* symptomatology,facilitating more precise and effective treatment strategies.

**SECONDARYOUTCOME**

It will facilitate thedocumentation of the siddha prognostic scorings for Low Back Pain in patientsundergoing Siddha management.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Patients with clinical symptoms of Low Back Pain, along with X-ray, CT or MRI findings associates with Low Back Pain.

Exclusion Criteria
  • Patients under 18 and above 70 yrs of age.
  • Patients who not have willing to participate in the study.
  • Vulnerable group.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PRIMARY OUTCOMEBaseline 0th day
It will provide a systematic and standardized prognostic tool for Siddha clinicians, in the form of a scoring, and to develop a mobile application (Thandaga Track) to assess the prognosis of low back pain through Siddha symptomatology, facilitating more precise and effective treatment strategies.Baseline 0th day
Secondary Outcome Measures
NameTimeMethod
SECONDARY OUTCOMEIt will facilitate the documentation of the siddha prognostic scorings for Low Back Pain in patients undergoing Siddha management.

Trial Locations

Locations (1)

Ayothidoss Pandithar Hospital, National Institute of Siddha.

🇮🇳

Kancheepuram, TAMIL NADU, India

Ayothidoss Pandithar Hospital, National Institute of Siddha.
🇮🇳Kancheepuram, TAMIL NADU, India
Dr ULAGAMADHAVAN M
Principal investigator
09842706576
ulagamadhavanm98@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.